Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $26.20M in the quarter ending June 30, 2025, with 83.75% growth. This brings the company's revenue in the last twelve months to $77.21M, up 24.49% year-over-year. In the year 2024, Theravance Biopharma had annual revenue of $64.38M with 12.12% growth.

• Revenue (ttm): $77.21M
• Revenue Growth: +24.49%
• P/S Ratio: 8.86
• Revenue / Employee: $795,928
• Employees: 97
• Market Cap: 694.73M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	64.38M	6.96M	12.12%
Dec 31, 2023	57.42M	6.08M	11.84%
Dec 31, 2022	51.35M	-3.97M	-7.17%
Dec 31, 2021	55.31M	-16.55M	-23.03%
Dec 31, 2020	71.86M	-1.56M	-2.12%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.